Cargando…
Lycorine: A prospective natural lead for anticancer drug discovery
Nature is the most abundant source for novel drug discovery. Lycorine is a natural alkaloid with immense therapeutic potential. Lycorine is active in a very low concentration and with high specificity against a number of cancers both in vivo and in vitro and against various drug-resistant cancer cel...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127747/ https://www.ncbi.nlm.nih.gov/pubmed/30114645 http://dx.doi.org/10.1016/j.biopha.2018.07.147 |
_version_ | 1783516426816978944 |
---|---|
author | Roy, Mridul Liang, Long Xiao, Xiaojuan Feng, Peifu Ye, Mao Liu, Jing |
author_facet | Roy, Mridul Liang, Long Xiao, Xiaojuan Feng, Peifu Ye, Mao Liu, Jing |
author_sort | Roy, Mridul |
collection | PubMed |
description | Nature is the most abundant source for novel drug discovery. Lycorine is a natural alkaloid with immense therapeutic potential. Lycorine is active in a very low concentration and with high specificity against a number of cancers both in vivo and in vitro and against various drug-resistant cancer cells. This review summarized the therapeutic effect and the anticancer mechanisms of lycorine. At the same time, we have discussed the pharmacology and comparative structure-activity relationship for the anticancer activity of this compound. The researches outlined in this paper serve as a foundation to explain lycorine as an important lead compound for new generation anticancer drug design and provide the principle for the development of biological strategies to utilize lycorine in the treatment of cancers. |
format | Online Article Text |
id | pubmed-7127747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71277472020-04-08 Lycorine: A prospective natural lead for anticancer drug discovery Roy, Mridul Liang, Long Xiao, Xiaojuan Feng, Peifu Ye, Mao Liu, Jing Biomed Pharmacother Article Nature is the most abundant source for novel drug discovery. Lycorine is a natural alkaloid with immense therapeutic potential. Lycorine is active in a very low concentration and with high specificity against a number of cancers both in vivo and in vitro and against various drug-resistant cancer cells. This review summarized the therapeutic effect and the anticancer mechanisms of lycorine. At the same time, we have discussed the pharmacology and comparative structure-activity relationship for the anticancer activity of this compound. The researches outlined in this paper serve as a foundation to explain lycorine as an important lead compound for new generation anticancer drug design and provide the principle for the development of biological strategies to utilize lycorine in the treatment of cancers. Elsevier Masson SAS. 2018-11 2018-08-14 /pmc/articles/PMC7127747/ /pubmed/30114645 http://dx.doi.org/10.1016/j.biopha.2018.07.147 Text en © 2018 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Roy, Mridul Liang, Long Xiao, Xiaojuan Feng, Peifu Ye, Mao Liu, Jing Lycorine: A prospective natural lead for anticancer drug discovery |
title | Lycorine: A prospective natural lead for anticancer drug discovery |
title_full | Lycorine: A prospective natural lead for anticancer drug discovery |
title_fullStr | Lycorine: A prospective natural lead for anticancer drug discovery |
title_full_unstemmed | Lycorine: A prospective natural lead for anticancer drug discovery |
title_short | Lycorine: A prospective natural lead for anticancer drug discovery |
title_sort | lycorine: a prospective natural lead for anticancer drug discovery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127747/ https://www.ncbi.nlm.nih.gov/pubmed/30114645 http://dx.doi.org/10.1016/j.biopha.2018.07.147 |
work_keys_str_mv | AT roymridul lycorineaprospectivenaturalleadforanticancerdrugdiscovery AT lianglong lycorineaprospectivenaturalleadforanticancerdrugdiscovery AT xiaoxiaojuan lycorineaprospectivenaturalleadforanticancerdrugdiscovery AT fengpeifu lycorineaprospectivenaturalleadforanticancerdrugdiscovery AT yemao lycorineaprospectivenaturalleadforanticancerdrugdiscovery AT liujing lycorineaprospectivenaturalleadforanticancerdrugdiscovery |